Pet Cancer Therapeutics Market

1. Pet Cancer Therapeutics Market by Type, Application, Element - Global Trends and Forecast to 2030 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

2. Global Pet Cancer Therapeutics Market • The pet cancer therapeutics market is speculated to garner considerable gains by 2027 due to rising pet care expenditure across the globe. • Surging prevalence of cancer among pets has augmented the need for more comprehensive predictive animal models, which has led to an increase in R&D activities in pet cancer therapeutics. Moreover, growing awareness among pet owners regarding pet diseases and therapeutics has propelled industry adoption in recent years. • Notably, industry players have been implementing lucrative initiatives to monetize emerging trends in the market, which has favorably impacted overall business dynamics. For instance, in January 2021, Anivive Lifesciences, a key pharmaceutical company specializing in pet therapeutics, received FDA approval for its novel antineoplastic therapeutic, dubbed the LAVERDIA-CA1. LAVERDIA-CA1 is the first canine-specific small-molecule selective inhibitor of nuclear export (SINE) medication for lymphoma. • To access a sample copy or view the market report in detail along with the table of • contents, please click the link below: https://www.gminsights.com/request-sample/detail/2017 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

3. Continue:- • The pet cancer therapeutics market has been segmented on the basis of application, therapy, species, route of administration, and region. With respect to therapy, the market has further been categorized into combination therapy, chemotherapy, targeted therapy, and immunotherapy. • In 2020, the targeted therapy sub-segment accounted for a sizable market share with a valuation of more than USD 32 million and is slated to progress at a steady pace over 2021-2027. The versatility of the procedure, coupled with novel advancements in the field of targeted cancer therapy, is estimated to boost segmental growth through the assessment period. • By route of administration, the market has been classified into injection and oral. The pet cancer therapeutics industry share from the oral sub-segment recorded a valuation of nearly USD 80 million in 2020 and is set to observe sturdy expansion over the study timeline. This growth is attributed to the ease of administration of drugs through oral methods. • From the species point of view, the pet cancer therapeutics market has been divided into cats and dogs. The dogs sub-segment held the lion's share of around 95% in the market in 2020 and is projected to expand at a robust pace through the forecast timeframe. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

4. 360° Industry Analysis • Browse key industry insights spread across xx pages with 184 market data tables & 18 figures & charts from the report, “Pet Cancer Therapeutics Market Size By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Combination Therapy), By Route of Administration (Oral, Injection), By Species (Dogs, Cats), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer), COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:https://www.gminsights.com/industry-analysis/pet-cancer-therapeutics-market • In terms of application, the pet cancer therapeutics market has been segregated into mammary and squamous cell cancer, lymphoma, melanoma, mast cell cancer, and others. The melanoma sub-segment is anticipated to exceed a valuation of USD 96 million by the end of 2027 on account of mounting incidences of melanoma. • On the regional front, the Latin America pet cancer therapeutics industry was worth over USD 1.8 million in 2020 and is poised to witness optimistic development due to rising awareness among pet owners regarding pet cancer diagnostics and therapeutics. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

5. Partial Table of Contents (ToC) of the report: • Chapter 1   Methodology & Scope • 1.1    Market definitions • 1.2    Base estimates and working • 1.3    Forecast parameters • 1.4    Data validation • 1.5    Data sources • 1.5.1    Secondary • 1.5.1.1   Paid sources • 1.5.1.2   Unpaid sources • 1.5.2    Primary • Chapter 2   Executive Summary • 2.1    Pet cancer therapeutics industry 360° synopsis, 2017 - 2030 • 2.1.1    Business trends • 2.1.2    Therapy trends © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

6. Key Players : • Elanco Animal Health,  • Zoetis Inc., • Merial Inc.,  • AB Science,  • Anivive Lifesciences,  • Qbiotics, • ELIAS Animal Health. • Browse complete table of content of this report@ https://www.gminsights.com/industry-analysis/pet-cancer-therapeutics-market#:~:text=Pet%20Cancer%20Therapeutics%20Market%20size%20registered%20a%20valuation%20of%20over,11.2%25%20from%202022%20to%202030.&text=Rising%20pet%20adoption%20will%20increase%20the%20demand%20for%20pet%20cancer%20therapeutics

7. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com